Cardlytics, Inc.
CDLX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.07 | 0.11 | 0.03 | -0.00 |
| FCF Yield | 1.41% | -7.10% | -0.77% | -2.42% |
| EV / EBITDA | -407.99 | -66.05 | -51.40 | -2.33 |
| Quality | ||||
| ROIC | -4.49% | -4.94% | -2.83% | -50.94% |
| Gross Margin | 47.23% | 40.65% | 44.24% | 42.58% |
| Cash Conversion Ratio | -0.02 | -0.13 | 0.50 | -0.19 |
| Growth | ||||
| Revenue 3-Year CAGR | -6.01% | -3.50% | -2.59% | -1.92% |
| Free Cash Flow Growth | 118.27% | -360.26% | 62.37% | -804.67% |
| Safety | ||||
| Net Debt / EBITDA | -271.78 | -42.35 | -23.23 | -1.15 |
| Interest Coverage | -5.30 | -5.93 | -3.51 | -63.05 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 132.24 | 133.71 | 122.16 | 137.86 |